Skip to content

Clinical trials

Phase 2 Neuroectodermal Tumors, Primitive, Peripheral trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroectodermal Tumors, Primitive, Peripheral Phase: Phase 2 Country / region: Australia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20101
20171
20181
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
Children's Oncology Group3
Eastern Cooperative Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroectodermal Tumors, Primitive, Peripheral12
Sarcoma11
Osteosarcoma7
Medulloblastoma6
Neuroblastoma6
Central Nervous System Neoplasms5
Ependymoma4
Glioma4
Hepatoblastoma4
Histiocytosis, Langerhans-Cell4

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.